“Real-World Clinician- and Patient-Reported Outcomes and Treatment Persistence Following Bimekizumab Initiation in Patients With Psoriasis: 6-Month Results from the PPD CorEvitas Psoriasis Registry”. 2025. SKIN The Journal of Cutaneous Medicine 9 (6): s632. https://doi.org/10.25251/6744kd41.